Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK-0364 in overweight and obese patients with type 2 diabetes mellitus
2006-002544-28Phase 2Terminated
- Sponsor
- Merck & Co.
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of taranabant in obesity and type 2 diabetes mellitus (T2DM) (4 arms), sponsored by Merck & Co. Primary endpoints: Body weight change and HbA1c change. Started Sep 2006; status: terminated.
02
Drugs
taranabant
03
Conditions
obesitytype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2006-002544-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002544-28.